Dr. Foster is the Senior Scientist at Sunnybrook Health Research Institute. He previously co-founded VisualSonics, an ultra high frequency ultrasound company that was sold to Sonosite in 2010.

Dr. DaCosta is the senior co-inventor of the PRODIGI platform. He is currently the Chair of Cancer Imaging, Cancer Care Ontario. He is also a Principal Investigator at the Ontario Cancer Institute, UHN. Dr. DaCosta received his PhD from the Department of Medical Biophysics, University of Toronto. His graduate research helped to develop and commercialize fluorescence endoscopic imaging technology for early diagnosis of gastrointestinal cancers.

Sam Ifergan is the President of iGan Partners, a growth capital firm that invests in medical devices/healthcare IT and internet/software companies. He previously co-founded VisualSonics, an ultra high frequency ultrasound company that was sold to Sonosite in 2010.

William Wignall is the President and CEO of Sangoma Technologies, a TSX listed company. He was previously President and CEO of Truition Inc and Electronics Workbench.

Nitesh is the VP of Manufacturing at MolecuLight. He was previously VP of Manufacturing at VisualSonics, an ultra high frequency ultrasound company that was sold to Sonosite in 2010. Nitesh held previous positions as the Manager of Operations at Dicom Information Technology and as the Production Manager at Quinton Electrophysiology Corporation, a cardiac medical device manufacturer .

Catherine is the VP of Marketing and Product Management at MolecuLight. She was previously the Director of Product Management at VisualSonics, an ultra high frequency ultrasound company that was sold to Sonosite in 2010.